Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong
· Delayed Price · Currency is HKD 5.62
0.00 (0.00%)
Jul 24, 2024, 4:00 AM HKT
Venus Medtech (Hangzhou) Revenue
In the year 2024, Venus Medtech (Hangzhou) had annual revenue of 470.83M CNY, down -4.18%. Venus Medtech (Hangzhou) had revenue of 240.11M in the half year ending December 31, 2024, with 22.20% growth.
Revenue
470.83M CNY
Revenue Growth
-4.18%
P/S Ratio
2.24
Revenue / Employee
681.38K CNY
Employees
691
Market Cap
1.12B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Akeso | 2.26B |
| CSPC Pharmaceutical Group | 30.87B |